Experimental Zebrafish Models of Mitochondrial Dysfunction in the Pathogenesis of CNS Diseases

被引:2
|
作者
Yushko, L. V. [1 ]
Kotova, M. M. [1 ]
Vyunova, T. V. [2 ]
Kalueff, A. V. [1 ,3 ,4 ,5 ,6 ]
机构
[1] Sirius Univ Sci & Technol, Sirius, Fed Territory S, Russia
[2] Life Improvement Future Technol LIFT Ctr, Moscow, Russia
[3] Minist Hlth Russian Federat, Almazov Natl Med Res Ctr, World class Sci Res Ctr Ctr Personalized Med, St Petersburg, Russia
[4] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia
[5] Minist Hlth Russian Federat, Granov Sci Res Ctr Radiol & Surg Technol, Preclin Bioscreening Grp, St Petersburg, Russia
[6] Sci Res Inst Neurosci & Med, Lab Translat Biopsychiatry, Novosibirsk, Russia
关键词
mitochondria; mitochondrial dysfunction; CNS diseases; model organisms; zebrafish; PARKINSONS-DISEASE; OXIDATIVE STRESS; MOUSE MODEL; MICE; FEATURES; THERAPY; HYPOXIA; GENOME;
D O I
10.1134/S0022093023060170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial dysfunctions are associated with pathogenesis of various brain disorders, including Alzheimer's, Parkinson's and Huntington's diseases, amyotrophic lateral sclerosis, Leigh syndrome, and autism spectrum disorder. For studying mitochondrial dysfunction, as well as developing and testing new therapeutic strategies, in vivo studies on zebrafish (Danio rerio) are of particular interest due to their biological characteristics, practical laboratory maintenance, and high throughput. Here, we address genetic and pharmacological models of common mitochondrial dysfunctions and related neurological disorders in rodents and zebrafish, focusing of the growing utility of these fish in modeling mitochondrial pathogenesis of various CNS diseases.
引用
收藏
页码:2114 / 2128
页数:15
相关论文
共 50 条
  • [41] Mitochondrial Dysfunction and Neurodegenerative Diseases
    Byvaltsev, Vadim
    Sudakov, N.
    Nikiforov, S.
    Konstantinov, Yu.
    WORLD NEUROSURGERY, 2010, 74 (01) : 10 - 12
  • [42] Mitochondrial Dysfunction in Demyelinating Diseases
    Carvalho, Karen S.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2013, 20 (03) : 194 - 201
  • [43] Mitochondrial dysfunction in fibrotic diseases
    Li, Xinyu
    Zhang, Wei
    Cao, Qingtai
    Wang, Zeyu
    Zhao, Mingyi
    Xu, Linyong
    Zhuang, Quan
    CELL DEATH DISCOVERY, 2020, 6 (01)
  • [44] Mitochondrial Dysfunction in Neurodegenerative Diseases
    Yang, Han-Mo
    CELLS, 2025, 14 (04)
  • [45] Mitochondrial dysfunction in fibrotic diseases
    Xinyu Li
    Wei Zhang
    Qingtai Cao
    Zeyu Wang
    Mingyi Zhao
    Linyong Xu
    Quan Zhuang
    Cell Death Discovery, 6
  • [46] Mitochondrial dysfunction in neurodegenerative diseases
    Beal, MF
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1366 (1-2): : 211 - 223
  • [47] Mitochondrial Dysfunction in Neurodegenerative Diseases
    Johri, Ashu
    Beal, M. Flint
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03): : 619 - 630
  • [48] Mitochondrial Dysfunction in Neurodegenerative Diseases
    Anthony H. V. Schapira
    Neurochemical Research, 2008, 33 : 2502 - 2509
  • [49] Mitochondrial Dysfunction in Cardiovascular Diseases
    Yang, Han-Mo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [50] Diseases caused by mitochondrial dysfunction
    Halmos Tamas
    Suba Ilona
    ORVOSI HETILAP, 2022, 163 (35) : 1383 - 1393